Young Americans Could Soon Be Eligible For COVID Vaccines

Pfizer says their vaccine is effective in children.

Video Transcript

- Millions of young Americans could soon be eligible for the coronavirus vaccine. CBS 4's Skyler Henry has the details from the White House.

SKYLER HENRY: A federal health official tells CBS News the FDA plans to authorize the Pfizer vaccine for children aged 12 to 15 as early as next week.

DR. ASHISH JHA: I have two kids in that age range. And they're both very excited to get it. And I'm happy for them to get it because I really do think these vaccines are both remarkably effective and quite safe.

SKYLER HENRY: Pfizer says clinical trials showed the vaccine was 100% effective in children that age and is well tolerated.

DR. REGINALD WASHINGTON: The antibody response is actually higher than the antibody response we've observed in adults, young adults. And also, there were no positive cases in the study group with the data that I've been able to obtain.

SKYLER HENRY: Pfizer and Moderna are now running clinical trials for kids six months old and older. This comes as the number of adults getting vaccinated continues to drop to an average of about 2.3 million doses per day. That's down from a high of more than three million doses per day just last month.

DR. REGINALD WASHINGTON: To reach herd immunity, we need a certain number of the general population, including this age group, to be vaccinated.

SKYLER HENRY: But the number of new coronavirus cases is dropping as well, prompting more states to lift all COVID restrictions.

RON DESANTIS: I think folks that are saying that they need to be policing people at this point, if you're saying that, you really are saying you don't believe in the vaccines.

SKYLER HENRY: But health officials are still urging caution as the variants of the virus are now spreading among unvaccinated young adults. Skyler Henry, CBS News, the White House.

- Well, Pfizer has been distributing its vaccine under an emergency use authorization from the FDA. But the drug manufacturer says it now has the six months of data showing the vaccine is safe that would be needed for full approval.